Categories: Artificial IntelligenceBioTechBodyEngineeringFoodTechHealthTechITOwnPlatformProduct
Lembas is redefining nutrition for the GLP-1 era. We craft natural, functional foods designed to work with biology - not against it. Our formulations are built for focus, recovery, and longevity, empowering a new generation of eaters to nourish smarter, not more. Explore how Lembas is re-engineering food for a world where better health begins within.
Investors 1
Mentions in press and media 5
| Date | Title | Description |
| 14.10.2025 | Breaking: Italy’s Maia Ventures launches $64m agrifood fund backed by EIF and others | Italy-based impact fund Maia Ventures has launched its first fund at €55 million ($64 million) that will support early-stage food and ag ventures addressing health, resilience, and efficiency in the food system.
The fund is fully operationa... |
| 23.06.2025 | Shiru invites brands to harness its AI platform to explore ‘natural’ GLP-1 activation: ‘The opportunity is immense’ | Shiru, a startup deploying AI to aid in ingredient discovery, is inviting food companies to use its platform to explore ingredients that naturally stimulate production of GLP-1, a gut hormone associated with appetite regulation.
The new GLP... |
| 11.06.2025 | Lembas Raises $3.6M in Pre-Seed Funding | Lembas GLP-1 Edge shown in multiple formats- gummies, powder, and capsules- designed to support metabolism and appetite regulation through science-backed, food-grade bioactives for weight management
Lembas, a Tel Aviv, Israel-based AI-power... |
| 10.06.2025 | ‘Pharma is eating Big Food’s lunch…’ Lembas fights back with GLP-1 boosting peptide | Israeli foodtech startup Lembas has emerged from stealth with “GLP-1 Edge,” a bioactive peptide that triggers the production of GLP-1 and other gut hormones that regulate appetite and metabolism.
Founded in 2024 by Shay Hilel (CEO), Dr. Zoh... |
| - | Lembas | “HOME | Lembas” |
Reviews 0
